Skip to main content
TipRanks
Go Ultimate75% OFF

Resonance Health Ltd (RHT) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

Resonance Health Ltd has a market cap or net worth of AUD 51.56M. The enterprise value is AUD 19.92M.

Market Cap
AUD 51.56M
Enterprise Value
AUD 19.92M

Share Statistics

Resonance Health Ltd has 560,453,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
560,453,550
Owned by Insiders
14.32%
Owned by Institutions
―

Financial Efficiency

Resonance Health Ltd’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 10.26%.

Return on Equity (ROE)
0.14
Return on Assets (ROA)
0.08
Return on Invested Capital (ROIC)
10.26%
Return on Capital Employed (ROCE)
0.13
Revenue Per Employee
875.11K
Profits Per Employee
84.06K
Employee Count
18
Asset Turnover
0.84
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Resonance Health Ltd is 27.50. Resonance Health Ltd’s PEG ratio is 0.07.

PE Ratio
27.50
PS Ratio
3.13
PB Ratio
3.77
Price to FCF
17.70
Price to Operating Cash Flow
14.55
PEG Ratio
0.07

Income Statement

In the last 12 months, Resonance Health Ltd had revenue of 15.75M and earned 1.51M in profits. Earnings per share was 0.00.

Revenue
15.75M
Gross Profit
14.80M
Operating Income
1.53M
Pretax Income
1.10M
Net Income
1.51M
EBITDA
2.48M
Earnings Per Share (EPS)
0.00

Cash Flow

In the last 12 months, operating cash flow was 2.88M and capital expenditures -94,768, giving a free cash flow of 2.79M billion.

Operating Cash Flow
2.88M
Free Cash Flow
2.79M
Free Cash Flow per Share
0.01

Dividends & Yields

Resonance Health Ltd pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
5.40%
Earnings Yield
3.45%

Stock Price Statistics

Beta
1.71
52-Week Price Change
87.76%
50-Day Moving Average
0.07
200-Day Moving Average
0.05
Relative Strength Index (RSI)
66.67
Average Volume (3m)
615.84K

Important Dates

Resonance Health Ltd upcoming earnings date is Feb 19, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2026
Next Earnings Date
Feb 19, 2027
Ex-Dividend Date
―

Financial Position

Resonance Health Ltd as a current ratio of 1.13, with Debt / Equity ratio of 34.29%

Current Ratio
1.13
Quick Ratio
1.13
Debt to Market Cap
0.13
Net Debt to EBITDA
-0.42
Interest Coverage Ratio
4.52

Taxes

In the past 12 months, Resonance Health Ltd has paid -413.63K in taxes.

Income Tax
-413.63K
Effective Tax Rate
-0.38

Enterprise Valuation

Resonance Health Ltd EV to EBITDA ratio is 20.33, with an EV/FCF ratio of 18.13.

EV to Sales
3.21
EV to EBITDA
20.33
EV to Free Cash Flow
18.13
EV to Operating Cash Flow
17.54

Balance Sheet

Resonance Health Ltd has AUD 4.85M in cash and marketable securities with AUD 3.81M in debt, giving a net cash position of AUD 1.04M billion.

Cash & Marketable Securities
AUD 4.85M
Total Debt
AUD 3.81M
Net Cash
AUD 1.04M
Net Cash Per Share
AUD 0.00
Tangible Book Value Per Share
AUD 0.00

Margins

Gross margin is 93.95%, with operating margin of 9.72%, and net profit margin of 9.61%.

Gross Margin
93.95%
Operating Margin
9.72%
Pretax Margin
6.98%
Net Profit Margin
9.61%
EBITDA Margin
15.77%
EBIT Margin
9.72%

Analyst Forecast

The average price target for Resonance Health Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
42.25%
EPS Growth Forecast
―

Scores

Smart Score
8
AI Score
71